Actinium Pharmaceuticals, Inc. - Director's Dealing 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Actinium Pharmaceuticals, Inc. (ATNM)
CIK: 0001388320
Period of Report: 2016-06-30

Reporting Person: Memorial Sloan-Kettering Cancer Center (10% Owner)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-06-30	Common Stock	S	15200	$1.8	Disposed	5140786	Direct
2016-06-30	Common Stock	S	300	$1.8025	Disposed	5140486	Direct
2016-06-30	Common Stock	S	300	$1.805	Disposed	5140186	Direct
2016-06-30	Common Stock	S	3350	$1.82	Disposed	5136836	Direct
2016-07-01	Common Stock	S	44841	$1.8	Disposed	5091995	Direct
2016-07-01	Common Stock	S	3200	$1.8001	Disposed	5088795	Direct
2016-07-01	Common Stock	S	200	$1.8015	Disposed	5088595	Direct
2016-07-01	Common Stock	S	100	$1.8025	Disposed	5088495	Direct
2016-07-01	Common Stock	S	11350	$1.805	Disposed	5077145	Direct
2016-07-01	Common Stock	S	25800	$1.81	Disposed	5051345	Direct
2016-07-01	Common Stock	S	7362	$1.8101	Disposed	5043983	Direct
2016-07-01	Common Stock	S	200	$1.8115	Disposed	5043793	Direct
2016-07-01	Common Stock	S	4300	$1.815	Disposed	5039483	Direct
2016-07-01	Common Stock	S	13830	$1.82	Disposed	5025653	Direct
2016-07-01	Common Stock	S	1400	$1.825	Disposed	5024253	Direct
2016-07-01	Common Stock	S	700	$1.83	Disposed	5023553	Direct
2016-07-01	Common Stock	S	3617	$1.85	Disposed	5019936	Direct
2016-07-01	Common Stock	S	100	$1.855	Disposed	5019836	Direct
2016-07-01	Common Stock	S	5900	$1.86	Disposed	5013936	Direct
2016-07-01	Common Stock	S	1400	$1.865	Disposed	5012536	Direct
2016-07-01	Common Stock	S	1700	$1.87	Disposed	5010836	Direct
2016-07-01	Common Stock	S	2550	$1.88	Disposed	5008286	Direct
2016-07-01	Common Stock	S	100	$1.9	Disposed	5008186	Direct
2016-07-01	Common Stock	S	300	$1.91	Disposed	5007886	Direct